GRI Bio Inc. (GRI) — Cash Flow-to-Debt Ratio
GRI Bio Inc. (GRI) has a Cash Flow-to-Debt Ratio of -4.64x as of March 2026, meaning its operating cash flow of $-3.69 Million could theoretically repay -5% of its total liabilities ($794.00K) in one year. Check GRI Bio Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GRI Bio Inc. Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for GRI Bio Inc. across 8 annual periods. Also explore GRI current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for GRI Bio Inc. (2018–2025)
Year-by-year debt coverage analysis for GRI Bio Inc.. For market capitalisation and broader financial context, see GRI Bio Inc. (GRI) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.83x | $-10.19 Million | $2.66 Million | ▲ +24.0% |
| 2024 | -5.04x | $-8.61 Million | $1.71 Million | ▼ -51.3% |
| 2023 | -3.33x | $-8.99 Million | $2.70 Million | ▼ -516.9% |
| 2022 | -0.54x | $-1.08 Million | $2.01 Million | ▼ -215.3% |
| 2021 | -0.17x | $-847.00K | $4.94 Million | ▲ +88.9% |
| 2020 | -1.54x | $-3.71 Million | $2.41 Million | ▲ +43.4% |
| 2019 | -2.72x | $-2.88 Million | $1.06 Million | ▲ +44.3% |
| 2018 | -4.88x | $-2.37 Million | $486.29K | — |